Fulgent Genetics Inc
NASDAQ:FLGT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Fulgent Genetics Inc
Minority Interest
Fulgent Genetics Inc
Minority Interest Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Minority Interest
-$5.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Minority Interest
$379m
|
CAGR 3-Years
49%
|
CAGR 5-Years
25%
|
CAGR 10-Years
14%
|
|
|
CVS Health Corp
NYSE:CVS
|
Minority Interest
$168m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
14%
|
|
|
Cigna Corp
NYSE:CI
|
Minority Interest
$161m
|
CAGR 3-Years
27%
|
CAGR 5-Years
20%
|
CAGR 10-Years
8%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Minority Interest
$16.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fulgent Genetics Inc
Glance View
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in Temple City, California and currently employs 645 full-time employees. The company went IPO on 2016-09-28. The firm develops a technology platform, which offers a test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. The company also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.
See Also
What is Fulgent Genetics Inc's Minority Interest?
Minority Interest
-5.3m
USD
Based on the financial report for Dec 31, 2025, Fulgent Genetics Inc's Minority Interest amounts to -5.3m USD.
What is Fulgent Genetics Inc's Minority Interest growth rate?
Minority Interest CAGR 1Y
-30%
Over the last year, the Minority Interest growth was -30%.
